title: PARP inhibitor treatment in ovarian and breast cancer.
authors.affiliation: Division of Cancer Development and Therapeutics, National Institutes of Health, National Cancer Institute, Rockville, MD 20892, USA.
authors.forename: Marcie K
authors.initials: MK
authors.lastname: Weil
authors.forename: Alice P
authors.initials: AP
authors.lastname: Chen
mesh_terms: D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics; D002277:Carcinoma / Q000188:drug therapy* / Q000235:genetics; D004260:DNA Repair / Q000235:genetics; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008954:Models, Biological; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000235:genetics; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D011065:Poly(ADP-ribose) Polymerases / Q000235:genetics / Q000378:metabolism
chemical_list: D004791:Enzyme Inhibitors; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D011065:Poly(ADP-ribose) Polymerases